Navigation Links
Pharsight to Present at B. Riley & Co. 9th Annual Las Vegas Investor Conference
Date:3/26/2008

MOUNTAIN VIEW, Calif., March 26 /PRNewswire-FirstCall/ -- Pharsight Corporation (Nasdaq: PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development announced today that it will be presenting at B. Riley & Co. 9th Annual Las Vegas Investor Conference on April 2, 2008 at the Palms Las Vegas. Shawn O'Connor, Pharsight's President and CEO, and William Frederick, Senior Vice President and CFO, will be presenting on April 2nd, at 1:30 p.m. PT.

Attendance at the conference is by invitation only. A live audio webcast of the presentation with slides will be broadcast via the Internet. The webcast can be viewed at the company's website under the investor relations section at http://www.pharsight.com.

About Pharsight Corporation

Pharsight Corporation develops and markets integrated products and services that enable pharmaceutical and biotechnology companies to achieve significant and enduring improvements in the development and use of therapeutic products. Pharsight's goal is to help customers reduce the time, cost and risk of drug development, as well as optimize the post-approval marketing and use of pharmaceutical products.

Pharsight's approach enhances the fundamental element of drug development success: strong decision-making. By adopting the Pharsight approach, customers acquire a new decision-making process with the potential to systematically improve every level and phase of their business and scientific processes. Pharsight Corporation is headquartered in Mountain View, California. Information about Pharsight is available at http://www.pharsight.c
'/>"/>

SOURCE Pharsight Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Pharsight Makes Strong Contribution to Inaugural American Conference on Pharmacometrics
2. Pharsights Reporting and Analysis Services Business Unit to Leverage New Validated Data Management System
3. Pharsight Welcomes Newest Japanese PKS, AutoPilot Customer
4. Pharsight to Present at Jesup and Lamont 2008 Emerging Growth Stock Conference
5. Pharsight Achieves $7.4 Million in Quarterly Revenue
6. Pharsight Announces Fiscal Third Quarter 2008 Earnings Release Date and Conference Call
7. Pharsights Reporting and Analysis Services Business Reaches Quality Assurance Milestone
8. Pharsight Signs Third WinNonlin(R) AutoPilot(TM) Customer
9. Pharsight Announces 1-For-3 Reverse Stock Split
10. Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China
11. Pharsight Invited to Present on Winning Strategies for R&D Productivity at New York Pharma Forum on October 15, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/11/2010)... WOODCLIFF LAKE, N.J. , March 11 Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a ... of functional blood cells. , ... , , ... ... ...
(Date:3/11/2010)... ... , , ... ... ... /PRNewswire/ - Today at ACAMP,s latest seminar, Alberta,s conventional energy industry learned how nanotechnology, micro-systems and micro-fluidics can play a powerful role in ...
(Date:3/11/2010)... Netherlands and SEATTLE, Washington , March 11, 2010 , ... medicine, today announced the,conclusion of the first Phase II trial testing its unique ... and efficacy (time to hemostasis),profiles for Fibrocaps, and good performance of the delivery ... ... ...
(Date:3/10/2010)... MISSISSAUGA, ON , March 10 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE YMI, ... million units at an issue price of US $1.20 for gross proceeds of ... half common share purchase warrant. Each whole warrant may be exercised to purchase one common ... ... ...
Breaking Biology Technology:FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 2FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 3FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 4FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 5FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 6FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 7FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS) 8Alberta companies delivering new products to the Conventional Energy marketplace 2Alberta companies delivering new products to the Conventional Energy marketplace 3ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief Medical Officer 2ProFibrix Reports Phase II Results of Hemostasis Product Fibrocaps(TM) and Appoints New Chief Medical Officer 3YM BioSciences closes US$17.5 million financing 2YM BioSciences closes US$17.5 million financing 3YM BioSciences closes US$17.5 million financing 4
... hit universities and colleges across the country, including ... copyright infringement of both movies and music over ... several cease-and-desist notices to the Universirty of Wisconsin- ... were hosting movie downloads with content that belonged ...
... Wisconsins economy prospered greatly during the agricultural and industrial ... of another turning point for Wisconsins economy; the innovation ... also be a leader in the coming innovation economy. ... a national priority, and we at the state and ...
... to evolve their technology expenditures from mere business expenses into ... of time. As legacy systems reach the end of their ... prioritized technology vision that addresses both business and employee needs. ... of voice and data to a single network is a ...
Other Biology Technology:File Swapping: Download at your own Risk 2File Swapping: Download at your own Risk 3Broadband Deployment & Adoption in Wisconsin 2Broadband Deployment & Adoption in Wisconsin 3Technology Investment in the Next 24 Months 2Technology Investment in the Next 24 Months 3
(Date:3/11/2010)... Materials scientists at the University of Wisconsin-Madison have ... energy and harness them to turn water into usable ... recycles otherwise-wasted energy into a useable form. , "This ... water splitting that may generate hydrogen fuels by scavenging ... the environment," the authors write in a new paper, ...
(Date:3/11/2010)... In most animal species, males and females show obvious ... given that both sexes share the same genes governing ... in moths and found clues that had been overlooked ... , Take a look around in the animal world ... of one sex are larger than the other of ...
(Date:3/11/2010)... its collective efforts to develop new drugs, the ... based on the application of natural biological transformation ... the cultivation of microorganisms or cells in a ... drug manufacture is subject to especially strict regulations, ... monitored precisely. Possibilities for analysis inside the reactor ...
Breaking Biology News(10 mins):Scavenging energy waste to turn water into hydrogen fuel 2Why female moths are big and beautiful 2Why female moths are big and beautiful 3Clean sampling from bioreactors 2Advanced Health Media Named to Deloittes 2009 Technology Fast 500 28TM 29 5680 1Advanced Health Media Named to Deloittes 2009 Technology Fast 500 28TM 29 5680 2Inhibikase Therapeutics Discusses New Platform for Infectious Disease Pharmaceuticals at BIOCOM 2009 5678 1Engineering center to probe forces that cause cancer to spread 60070 1Engineering center to probe forces that cause cancer to spread 60070 2Engineering center to probe forces that cause cancer to spread 60070 3Engineering center to probe forces that cause cancer to spread 60070 4Engineering center to probe forces that cause cancer to spread 60070 5Engineering center to probe forces that cause cancer to spread 60070 6
... ever, but the amount of data to be analyzed ... that genome sequence analysis can be made interactive and ... of data. , Researchers from the Department of ... their entry at the Supercomputing ,08 High Performance Computing ...
... In a study in the advance online edition of ... College of Medicine describe a technique for looking more ... a gene, DNA, being read into a message, mRNA. The ... genes are switched on inappropriately, causing disease. , The ...
... to biofuel crops can increase or decrease greenhouse gas emissions, ... used, University of Illinois researchers report this month. , The ... planting new biofuel crops can influence the carbon content of ... Global Change Biology Bioenergy . , Plants use the ...
Other Biology News:PNNL researchers earn top honors at Supercomputing conference 2PNNL researchers earn top honors at Supercomputing conference 3Einstein researchers develop technique to count messages made by single genes 2Replacing corn with perennial grasses improves carbon footprint of biofuels 2Replacing corn with perennial grasses improves carbon footprint of biofuels 3
...
p27 rabbit polyclonal antibody...
... Rabbit polyclonal to Ki67 - Proliferation Marker, ... cell cycle related nuclear protein, expressed by ... active cell cycle (G1, S, G2 and ... (G0) cells. Ki67 antibodies are useful in ...
UBC13 Antibody...
Biology Products: